Medical/Pharmaceuticals

Raya Therapeutic announces early-stage R&D collaboration with argenx

MONTREAL, July 12, 2023 /PRNewswire/ -- Raya Therapeutic Inc., ("Raya") a mission-driven company focused on the treatment of neurodegenerative diseases, has entered into an early-stage R&D collaboration with argenx. The collaboration focuses on testing combinations of Raya's pipeline of targeted ...

2023-07-12 19:07 2074

Best Presentation Award at EASL Congress 2023: First-in-class Bispecific Antibodies Anti-HBs×CD3 and Anti-HBs×CD28 Showed Strong Preclinical Efficacy in HBV Cure

SINGAPORE, July 12, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, together with researchers from the University Medical Center Hamburg-Eppendorf and Technical Unive...

2023-07-12 18:13 2368

Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation

SINGAPORE, July 12, 2023 /PRNewswire/ -- On July 6, 2023, Biosyngen received an official notification from the U.S. Food and Drug Administration (FDA) granting Fast Track Designation (FTD) to its revolutionary first-in-class immunotherapy, BRG01, for the treatment of relapsed/metastatic nasophary...

2023-07-12 13:38 2676

Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone.

SINGAPORE, July 12, 2023 /PRNewswire/ -- This is a model of cooperation between Singapore and China, more importantly, working jointly in the area of research and development. Through this initiative, China Singapore Knowledge City paths the way to attract both local and overseas therapeutic asse...

2023-07-12 10:32 2549

Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism

HANGZHOU, China and SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the publication of discovery, preclinical characteriza...

2023-07-12 10:00 2037

GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET®

BOSTON, July 11, 2023 /PRNewswire/ -- GI Dynamics, creator of the world's first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®. This transformative shift r...

2023-07-12 07:12 1998

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

TAIPEI, July 12, 2023 /PRNewswire/ -- As cell therapies continue to rank among the most expensive of cancer treatments,BeiGene is quietly charting a different path that would enable more equitable access for all.

2023-07-12 06:00 2040

DISCOVERY LIFE SCIENCES ACCELERATES CLINICAL TRIALS WITH ADDITION OF FULL-SPECTRUM CLINICAL FLOW CYTOMETRY

Integrates state-of-the-art flow cytometry clinical trial services with leading genomics, proteomics, and molecular pathology solutions under one roof HUNTSVILLE, Ala., July 11, 2023 /PRNewswire/ -- Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, announces the laun...

2023-07-11 20:05 2534

AXA Upgrades "Dr@Live" with New Features

One-stop service encompassing eQueuing, eAppointment, doctor consultation and same-day medicine delivery HONG KONG, July 11, 2023 /PRNewswire/ -- AXA Hong Kong & Macau ("AXA") announced today the launch of the enhanced "Dr@Live" medical service, providing a seamless one-stop health management ex...

2023-07-11 16:32 1971

Race executes global license agreement with City of Hope to access FTO IP

* Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations inthe United States. * Under the agreement, Race will exclusively secure rights to a City of Hope patent application and associated know-how identifying that bisantrene...

2023-07-11 07:30 1982

SOUND OF FREEDOM, EXECUTIVE PRODUCED BY GOYA CARES, SOARS IN THEATERS

Film Brings Evil into Light and Hope to Two Million Trafficked Children JERSEY CITY, N.J., July 11, 2023 /PRNewswire/ -- Goya Cares, an executive producer of the new blockbuster movie SOUND OF FREEDOM, celebrates the overwhelming success of surpassing the goal of over two million viewers to repr...

2023-07-11 07:25 2519

Shanghai Electric Shares A Long-term Cooperation Opportunity with Siemens, Strengthening Innovation in New Energy and Healthcare

SHANGHAI, July 11, 2023 /PRNewswire/ -- Shanghai Electric (SEHK:2727, SSE:601727) ("the Company") discussed the long-term cooperation opportunity with Siemens to boost technological innovation in the healthcare and energy sectors in a recent visit paid by the top executives from Siemens Healthine...

2023-07-11 07:09 2409

Quest PharmaTech Provides Product Development Update

EDMONTON, AB, July 11, 2023 /PRNewswire/ -- Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company"), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies announced that a U.S patent has been granted...

2023-07-11 04:30 1832

Rx-360 Expands Trademark Portfolio to Japan

PHILADELPHIA, July 10, 2023 /PRNewswire/ -- Rx-360 is pleased to announce that the consortium has now expanded their trademark registration for Joint Audit Program® logo to now include Japan.  Through the achievement of this milestone, Rx-360 has secured trademark registration for Rx360 and the J...

2023-07-10 18:00 1590

Atlas Associates Clinic Introduces Convenient House Calls for Enhanced Patient Care

SINGAPORE, July 10, 2023 /PRNewswire/ -- Atlas Associates Clinic is thrilled to announce the introduction ofhouse call services for patients. Recognising the importance of accessible and patient-centred healthcare, the clinic is bringing medical expertise directly to...

2023-07-10 16:07 1481

HOYA Group PENTAX Medical Established Manufacturing, R & D and Service Center in China

TOKYO, July 10, 2023 /PRNewswire/ -- HOYA Group, PENTAX Medical announced an establishment of endoscope manufacturing, R&D and service center dedicated to China market in Shanghai, China under PENTAX Medical Shanghai Co., Ltd. The manufacturing site is going to produce PENTAX Medical endoscopic s...

2023-07-10 16:00 1945

Calling Bright Minds in Southeast Asia, Bio Farma and MIT Hacking Medicine is Set to Revolutionize Healthcare with a 4-Day Hackathon

JAKARTA, Indonesia, July 10, 2023 /PRNewswire/ -- Bio Farma , Indonesia's state-owned Pharmaceutical company, is collaborating with MIT Hacking Medicine to address urgent healthcare challenges in the region by holding the first-everBio Farma x MIT Hacking Medicine Ha...

2023-07-10 15:19 2487

BRONCUS COMPLETES THE FIRST CASE OF REGISTERED CLINICAL TRIALS OF ITS TARGETED LUNG DENERVATION RADIOFREQUENCY ABLATION SYSTEM

HANGZHOU, China, July 10, 2023 /PRNewswire/ -- Broncus Holding Corporation (HKG:2216) has completed the first case of registered clinical trials of its targeted lung denervation (''TLD'') radiofrequency ablation system. The multi-center clinical randomized controlled trial on the ''treatment of C...

2023-07-10 12:56 2082

SIAF: Disrupted epithelial barriers as a predictor of severe COVID-19 development

Severe Covid-19 in epithelial barrier disrupted subjects DAVOS, Switzerland, July 10, 2023 /PRNewswire/ -- According to the epithelial barrier theory, disruption of epithelial barriers by environmental and toxic agents triggers microbial dysbiosis, bacterial translocation to subepithelial areas ...

2023-07-10 11:13 1940

RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors

The partnership focuses on combining novel antibody-drug conjugates RC88 and RC108 with a PD-1 inhibitor sintilimab for enhanced treatment outcomes YANTAI, China, July 10, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fu...

2023-07-10 10:24 2032
1 ... 54555657585960 ... 382